Ondrej Slanar (O Slanař, Ondřej Slanař)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 19

Top Topics

Venous Thromboembolism

Top Venues

Clinical and translational science

Antibiotics (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Jan Bosák, Martin Sima, Tereza Krejčí, Iva Obadalová, Jaroslava Šmardová, Petr Kozlík, Tomas Krizek, Josef Beránek, Tomáš Hauser, Ondrej Slanar
Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal regimes. Clinical and translational science 17 (5) (2024)
Jan Bosák, Martin Sima, Tereza Krejčí, Iva Obadalová, Jaroslava Šmardová, Petr Kozlík, Tomas Krizek, Josef Beránek, Tomáš Hauser, Ondrej Slanar
Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal regimes. Clinical and translational science 17 (5) (2024)
Zhiyuan Yang, Cristina Marcoci, Hatice Kübra Öztürk, Eleni Giama, Ayse Gertrude Yenicelik, Ondrej Slanar, Christopher Linington, Roshni Desai, Kenneth J Smith
Tissue Hypoxia and Associated Innate Immune Factors in Experimental Autoimmune Optic Neuritis. International journal of molecular sciences 25 (5) (2024)
Zhiyuan Yang, Cristina Marcoci, Hatice Kübra Öztürk, Eleni Giama, Ayse Gertrude Yenicelik, Ondrej Slanar, Christopher Linington, Roshni Desai, Kenneth J Smith
Tissue Hypoxia and Associated Innate Immune Factors in Experimental Autoimmune Optic Neuritis. International journal of molecular sciences 25 (5) (2024)
Jan Bosák, Martin Sima, Tereza Krejčí, Iva Obadalová, Jaroslava Šmardová, Petr Kozlík, Tomas Krizek, Josef Beránek, Tomáš Hauser, Ondrej Slanar
Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal regimes. Clinical and translational science 17 (5) (2024)
Lucie Polášková, Jan Miroslav Hartinger, Irena Murínová, Pavel Michálek, Ondrej Slanar, Martin Sima
Vancomycin loading dose individualization in a population of obese patients undergoing haemodialysis based on population pharmacokinetic model. Journal of chemotherapy (Florence, Italy) (2024)
Jan Bosák, Martin Sima, Tereza Krejčí, Iva Obadalová, Jaroslava Šmardová, Petr Kozlík, Tomas Krizek, Josef Beránek, Tomáš Hauser, Ondrej Slanar
Development of immediate-release formulation with reliable absorption of rivaroxaban in various meal regimes. Clinical and translational science 17 (5) (2024)
Zhiyuan Yang, Cristina Marcoci, Hatice Kübra Öztürk, Eleni Giama, Ayse Gertrude Yenicelik, Ondrej Slanar, Christopher Linington, Roshni Desai, Kenneth J Smith
Tissue Hypoxia and Associated Innate Immune Factors in Experimental Autoimmune Optic Neuritis. International journal of molecular sciences 25 (5) (2024)
Eliška Dvořáčková, Martin Sima, Andrea Zajacová, Kristýna Vyskočilová, Tereza Kotowski, Kateřina Dunovská, Eva Klapková, Jan Havlín, Robert Lischke, Ondrej Slanar
Dosing Optimization of Posaconazole in Lung-Transplant Recipients Based on Population Pharmacokinetic Model. Antibiotics (Basel, Switzerland) 12 (9) (2023)
Martin Sima, Ondrej Slanar
Dose Optimization and Targeting Strategies of Anti-Infective Agents. Pharmaceutics 15 (7) (2023)
Jiří Hofmann, Aleš Bartůněk, Tomáš Hauser, Gregor Sedmak, Josef Beránek, Pavel Ryšánek, Martin Sima, Ondrej Slanar
Dasatinib anhydrate containing oral formulation improves variability and bioavailability in humans. Leukemia (2023)
Jan Miroslav Hartinger, Danica Michaličková, Eliška Dvořáčková, Karolína Hronová, Elke H J Krekels, Barbora Szonowská, Vladimíra Bednářová, Hana Benáková, Gabriela Kroneislová, Jan Závora, Vladimir Tesar, Ondrej Slanar
Intraperitoneally Administered Vancomycin in Patients with Peritoneal Dialysis-Associated Peritonitis: Population Pharmacokinetics and Dosing Implications. Pharmaceutics 15 (5) (2023)
Irena Murínová, Martin Švidrnoch, Tomáš Gucký, Jan Hlaváč, Pavel Michálek, Ondrej Slanar, Martin Sima
Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Eliška Dvořáčková, Martin Sima, Jakub Petrus, Eva Klapková, Petr Hubáček, Jiří Pozniak, Jan Havlín, Robert Lischke, Ondrej Slanar
Ganciclovir Pharmacokinetics and Individualized Dosing Based on Covariate in Lung Transplant Recipients. Pharmaceutics 14 (2) (2022)
Martina Kodetova, Radka Hobzova, Jakub Sirc, Jiri Uhlik, Katerina Dunovska, Karel Svojgr, Ana-Irina Cocarta, Andrea Felsoova, Ondrej Slanar, Martin Sima, Igor Kozak, Pavel Pochop
The Role of Cryotherapy in Vitreous Concentrations of Topotecan Delivered by Episcleral Hydrogel Implant. Pharmaceutics 14 (5) (2022)
Jana Královičová, Aleš Bartůněk, Jiří Hofmann, Tomáš Křížek, Petr Kozlík, Jaroslava Roušarová, Pavel Ryšánek, Martin Sima, Ondrej Slanar
Pharmacokinetic Variability in Pre-Clinical Studies: Sample Study with Abiraterone in Rats and Implications for Short-Term Comparative Pharmacokinetic Study Designs. Pharmaceutics 14 (3) (2022)
Irena Murínová, Martin Švidrnoch, Tomáš Gucký, Jan Hlaváč, Pavel Michálek, Ondrej Slanar, Martin Sima
Population Pharmacokinetic Analysis Proves Superiority of Continuous Infusion in PK/PD Target Attainment with Oxacillin in Staphylococcal Infections. Antibiotics (Basel, Switzerland) 11 (12) (2022)
Martin Sima, Daniel Bobek, Petra Cihlářová, Pavel Ryšánek, Jaroslava Roušarová, Jan Beroušek, Martin Kuchar, Tomáš Vymazal, Ondrej Slanar
Factors Affecting the Metabolic Conversion of Ciprofloxacin and Exposure to Its Main Active Metabolites in Critically Ill Patients: Population Pharmacokinetic Analysis of Desethylene Ciprofloxacin. Pharmaceutics 14 (8) (2022)
O Bartošová, C Bonnet, Olga Ulmanová, Martin Sima, F Perlík, Evžen Růžička, Ondrej Slanar
Pupillometry as an indicator of L-DOPA dosages in Parkinson's disease patients. Journal of neural transmission (Vienna, Austria : 1996) 125 (4) (2017)